BioAtla (BCAB) Common Equity (2020 - 2026)
BioAtla's Common Equity was -$36.24 million in Q2 2026, compared with -$16.75 million a year earlier.
Powered by 
Analysis
BioAtla (BCAB) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at BioAtla came in at -$36.19 million.
- In earlier years, Common Equity was $14.27 million in FY2024 (-79.8%), $70.67 million in FY2023 (-60.8%), $180.34 million in FY2022 (-14.5%) and $210.82 million in FY2021 (+0.4%).
- Quarterly Common Equity has moved between -$37.31 million (Q1 2026) and $230.65 million (Q3 2021) over five years.
- The best year-over-year quarter for Common Equity over five years was Q4 2021 (growth of 0.4%); the worst was Q1 2025 (a decline of 98.9%).
- Per Business Quant data, BCAB's Common Equity in the three quarters before Q2 2026 was -$37.31 million (Q1 2026), -$36.19 million (Q4 2025) and -$31.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.13 Bn | 1,102.72 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 297.88 Bn | 261.87 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.36 Bn | 235.05 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 235.80 Bn | 191.20 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 190.78 Bn | 164.97 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 169.43 Bn | 116.08 Bn | 10.94 Bn | 85.49 Bn |
| 10 | BioAtla | 2.41 Mn | -16.54 Mn | - | -36.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -36.24 Mn |
| Mar 31, 2026 | -37.31 Mn |
| Dec 31, 2025 | -36.19 Mn |
| Sep 30, 2025 | -31.24 Mn |
| Jun 30, 2025 | -16.75 Mn |
| Mar 31, 2025 | 547,000.00 |
| Dec 31, 2024 | 14.27 Mn |
| Sep 30, 2024 | 22.97 Mn |
| Jun 30, 2024 | 31.37 Mn |
| Mar 31, 2024 | 49.72 Mn |
| Dec 31, 2023 | 70.67 Mn |
| Sep 30, 2023 | 94.70 Mn |
| Jun 30, 2023 | 124.52 Mn |
| Mar 31, 2023 | 156.43 Mn |
| Dec 31, 2022 | 180.34 Mn |
| Sep 30, 2022 | 142.63 Mn |
| Jun 30, 2022 | 164.95 Mn |
| Mar 31, 2022 | 190.05 Mn |
| Dec 31, 2021 | 210.82 Mn |
| Sep 30, 2021 | 230.65 Mn |
API Access
BioAtla Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BCAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BCAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BCAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();